Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zero Plus is a South Korean digital healthcare company specializing in the development of AI-powered medical devices and bio-signal analysis platforms. The company's flagship product, Z-STETH, is an intelligent stethoscope that utilizes deep learning algorithms to analyze heart and lung sounds in real-time, assisting clinicians in the early detection of cardiovascular and respiratory conditions. By integrating advanced acoustic sensors with cloud-based AI, Zero Plus aims to bridge the gap between traditional physical examinations and high-fidelity diagnostic imaging. Their technology is designed for use in both clinical settings and remote monitoring environments, facilitating telemedicine and proactive chronic disease management. The company is actively expanding its portfolio to include wearable sensors and comprehensive health monitoring solutions for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZERO PLUS.